Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated with increased atypical nevus counts. However, a clear relationship between pathogenic CDKN2A mutation carriage and other nevus phenotypes including counts of common acquired nevi has not yet been established. Using data from GenoMEL, we investigated the relationships between CDKN2A mutation carriage and 2-mm, 5-mm, and atypical nevus counts among blood-related members of melanoma families. Compared with individuals without a pathogenic mutation, those who carried one had an overall higher prevalence of atypical (odds ratio = 1.64; 95% confidence interval = 1.18\u20132.28) nevi but not 2-mm nevi (odds ratio = 1.06; 95% confidence interval = 0.9...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Australia has the highest incidence of melanoma in the world. Melanocytic nevi and mutations in the ...
Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated wi...
Melanocytic nevi are the most potent risk factors for melanoma yet identified. Variation in the nevu...
The total number of acquired melanocytic nevi on the skin is strongly correlated with melanoma risk....
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations i...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
The strongest known epidemiologic risk factor for melanoma is a large number of melanocytic nevi (Sw...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...
SummaryImportant risk factors for melanoma are densely clustered melanocytic nevi (common moles) and...
Approximately 10% of cases of human cutaneous malignant melanoma (CMM) have been estimated to occur ...
A high melanocytic nevi count is the strongest known risk factor for cutaneous melanoma. We conducte...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Australia has the highest incidence of melanoma in the world. Melanocytic nevi and mutations in the ...
Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated wi...
Melanocytic nevi are the most potent risk factors for melanoma yet identified. Variation in the nevu...
The total number of acquired melanocytic nevi on the skin is strongly correlated with melanoma risk....
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations i...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
The strongest known epidemiologic risk factor for melanoma is a large number of melanocytic nevi (Sw...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...
SummaryImportant risk factors for melanoma are densely clustered melanocytic nevi (common moles) and...
Approximately 10% of cases of human cutaneous malignant melanoma (CMM) have been estimated to occur ...
A high melanocytic nevi count is the strongest known risk factor for cutaneous melanoma. We conducte...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Australia has the highest incidence of melanoma in the world. Melanocytic nevi and mutations in the ...